GoodRx Holdings (GDRX) Treasury Shares (2019 - 2025)

GoodRx Holdings (GDRX) has 7 years of Treasury Shares data on file, last reported at $25.2 million in Q4 2025.

• For the quarter ending Q4 2025, Treasury Shares rose 12.67% year-over-year to $25.2 million; the trailing twelve-month figure through Dec 2025 stood at $25.2 million (up 12.67% YoY), and the FY2025 full-year result was $25.2 million, up 12.67% from the prior year.
• Treasury Shares rose to $25.2 million in Q4 2025, from $22.4 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $25.2 million in Q4 2025 to a low of $1.5 million in Q4 2023.
• A 5-year average of $10.2 million and a median of $6.2 million in 2022 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares plunged 97.02% in 2021 and surged 1353.48% in 2024, its largest moves.
• Tracing GDRX's Treasury Shares over 5 years: stood at $5.6 million in 2021, then slumped by 36.37% to $3.6 million in 2022, then tumbled by 57.15% to $1.5 million in 2023, then surged by 1353.48% to $22.4 million in 2024, then grew by 12.67% to $25.2 million in 2025.
• Business Quant data shows GDRX's Treasury Shares at $25.2 million in Q4 2025, $22.4 million in Q4 2024, and $1.5 million in Q4 2023.